Capital Fund Management (CFM)
WST icon

Capital Fund Management (CFM)’s West Pharmaceutical WST Stock Holding History

Capital Fund Management (CFM)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-8,100
Closed -$1.15M – 2072
2019
Q3 		$1.15M Buy
8,100
+1,700
+27% +$234K 0.01% 973
2019
Q2 		$801K Buy
+6,400
New +$755K 0.01% 1083

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Fund Management (CFM)'s WST Position: Q1 2026 in Review

Capital Fund Management (CFM) opened a new position in West Pharmaceutical (WST) in Q1 2026: 32,249 shares worth $8.08M. The stake represents 0.04% of the portfolio and ranks #649 among its holdings. This is a return to the name: Capital Fund Management (CFM) previously reported a position in WST as recently as Q3 2024.

Capital Fund Management (CFM) first reported a position in WST in Q1 2014 and has held it in 26 quarters since. The position peaked at $30.5M in Q2 2023. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Capital Fund Management (CFM) held 32,249 shares of West Pharmaceutical worth $8.08M as of Q1 2026.
  • West Pharmaceutical was a new Capital Fund Management (CFM) position in Q1 2026.
  • West Pharmaceutical made up 0.04% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #649 holding.
  • Capital Fund Management (CFM) first reported a position in West Pharmaceutical in Q1 2014 and has held it in 26 quarters since.
  • Capital Fund Management (CFM)'s West Pharmaceutical position peaked at $30.5M in Q2 2023.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.